OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Renal protective effects of astragaloside IV, in diabetes mellitus kidney damage animal models: A systematic review, meta-analysis
Xiaotao Zhou, Junju Zou, Chun Ao, et al.
Pharmacological Research (2020) Vol. 160, pp. 105192-105192
Closed Access | Times Cited: 29

Showing 1-25 of 29 citing articles:

Pharmacological potential of Astragali Radix for the treatment of kidney diseases
Yue Shi, Xiujie Shi, Mingming Zhao, et al.
Phytomedicine (2023) Vol. 123, pp. 155196-155196
Closed Access | Times Cited: 27

Modulation of the vitamin D receptor by traditional Chinese medicines and bioactive compounds: potential therapeutic applications in VDR-dependent diseases
Minghe Yao, Patrick Kwabena Oduro, Ayomide M. Akintibu, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 9

Astragalus Mongholicus: A review of its anti-fibrosis properties
Fengying Gong, Rongmei Qu, Yongchun Li, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 29

Moshen granule ameliorates membranous nephropathy by blocking intrarenal renin-angiotensin system signalling via the Wnt1/β-catenin pathway
Yanni Wang, Hua Miao, Meng-Ru Hua, et al.
Phytomedicine (2023) Vol. 114, pp. 154763-154763
Closed Access | Times Cited: 22

The intervention of cannabinoid receptor in chronic and acute kidney disease animal models: a systematic review and meta-analysis
Zihao Zhao, Qianqian Yan, Junwei Xie, et al.
Diabetology & Metabolic Syndrome (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 7

Astragaloside IV Alleviates Renal Tubular Epithelial-Mesenchymal Transition via CX3CL1-RAF/MEK/ERK Signaling Pathway in Diabetic Kidney Disease
Yonghui Hu, Wangna Tang, Wenjie Liu, et al.
Drug Design Development and Therapy (2022) Vol. Volume 16, pp. 1605-1620
Open Access | Times Cited: 25

Therapeutic Potential of Astragaloside IV Against Adriamycin-Induced Renal Damage in Rats via Ferroptosis
Lu-Yun Qin, Peng Guan, Jianxin Wang, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 24

Adiponectin protects against myocardial ischemia–reperfusion injury: a systematic review and meta-analysis of preclinical animal studies
Hongyi Yue, Qunhui Zhang, Senhao Chang, et al.
Lipids in Health and Disease (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 5

The role of macrophage-derived Exosomes in reversing peritoneal fibrosis: Insights from Astragaloside IV
Yun Shan, Manshu Yu, Huibo Dai, et al.
Phytomedicine (2024) Vol. 129, pp. 155683-155683
Closed Access | Times Cited: 5

Study on active components of mulberry leaf for the prevention and treatment of cardiovascular complications of diabetes
Yu Cao, Wei Jiang, Huixin Bai, et al.
Journal of Functional Foods (2021) Vol. 83, pp. 104549-104549
Open Access | Times Cited: 28

Therapeutic and delivery strategies of phytoconstituents for renal fibrosis
Huan Xu, Tianyi Wu, Leaf Huang
Advanced Drug Delivery Reviews (2021) Vol. 177, pp. 113911-113911
Closed Access | Times Cited: 28

Advancements in the Research of Astragalus membranaceus for the Treatment of Colorectal Cancer
Qiwen Lu, Jiaxin Jiang, Xi Wang, et al.
The American Journal of Chinese Medicine (2025), pp. 1-28
Closed Access

Astragaloside IV Attenuates the Myocardial Injury Caused by Adriamycin by Inhibiting Autophagy
Li-Fei Luo, Lu-Yun Qin, Jianxin Wang, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 23

Regulatory Effects of Astragaloside IV on Hyperglycemia-Induced Mitophagy in Schwann Cells
Xiaoyi Wei, Yalin Zheng, Yanke Ai, et al.
Evidence-based Complementary and Alternative Medicine (2022) Vol. 2022, pp. 1-8
Open Access | Times Cited: 11

Astragaloside IV protects against ischemia/reperfusion (I/R)-induced kidney injury based on the Keap1-Nrf2/ARE signaling pathway
Su Y, Jiaqi Xu, Siqi Chen, et al.
Translational Andrology and Urology (2022) Vol. 11, Iss. 8, pp. 1177-1188
Open Access | Times Cited: 11

Astragaloside IV improves the pharmacokinetics of febuxostat in rats with hyperuricemic nephropathy by regulating urea metabolism in gut microbiota
Zhen Xiong Zhao, Xiao Hui Tang, Sheng Lu Jiang, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 10

Effects of Danggui Buxue decoction on host gut microbiota and metabolism in GK rats with type 2 diabetes
Wenkai Wang, Fan Lü, Fan Ge, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 9

Astragaloside IV Alleviates Acute Liver Failure Induced by D-GalN/LPS by Upregulating Autophagy and Reducing Inflammation
Hong Meng, Wenwen Lian, Ying Yang, et al.
Infectious Microbes & Diseases (2024)
Open Access | Times Cited: 1

Cardioprotective effects of curcumin against Diabetic Cardiomyopathies: A systematic review and meta-analysis of preclinical studies
Wujiao Wang, Peifen Chang, Jialin Jin, et al.
Phytomedicine (2024) Vol. 129, pp. 155619-155619
Closed Access | Times Cited: 1

Potential Mechanisms of Methylglyoxal‐Induced Human Embryonic Kidney Cells Damage: Regulation of Oxidative Stress, DNA Damage, and Apoptosis
Dan Liu, Ye Cheng, Zhipeng Tang, et al.
Chemistry & Biodiversity (2021) Vol. 19, Iss. 2
Closed Access | Times Cited: 10

Page 1 - Next Page

Scroll to top